C12Y 305/04016
Gtp cyclohydrolase i
Official title: GTP cyclohydrolase I (3.5.4.16)
C12Y305/04016 (Gtp cyclohydrolase i) appears on 13 US grants and 34 published applications in this corpus.
Search patents in C12Y- Granted patents
- 13
- Published applications
- 34
- Assignees
- 19
- Inventors
- 71
- Latest grant
- 3 Jun 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 0 |
| 2010 | 0 | 2 |
| 2011 | 0 | 0 |
| 2012 | 1 | 1 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 3 |
| 2016 | 0 | 1 |
| 2017 | 1 | 2 |
| 2018 | 0 | 1 |
| 2019 | 0 | 3 |
| 2020 | 3 | 3 |
| 2021 | 1 | 2 |
| 2022 | 2 | 5 |
| 2023 | 0 | 4 |
| 2024 | 2 | 1 |
| 2025 | 2 | 3 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Genetic construct3 Jun 2025US 12,319,927 B2Healing Genes LLC
- Pterin-dependent biocatalysts and uses thereof3 Jun 2025US 12,319,948 B2Georgia Tech Research Corporation
- Methods of producing nor-opioid and nal-opioid benzylisoquinoline alkaloids31 Dec 2024US 12,180,525 B2Antheia, Inc.
- Optimized microbial cells for production of melatonin and other compounds9 Jan 2024US 11,866,749 B2Danmarks Tekniske Universitet
- Methods of producing nor-opioid and nal-opioid benzylisoquinoline alkaloids26 Jul 2022US 11,396,668 B2Antheia, Inc.
- Gene sequence construct used for treatment of central nervous system diseases30 Apr 2026US 2026/0117234 A1
- Genetic Construct2 Oct 2025US 2025/0305001 A1Healing Genes LLC
- Expression vectors composition4 Sep 2025US 2025/0277203 A1Maavrx Ltd
- Methods of producing nor-opioid and nal-opioid benzylisoquinoline alkaloids1 May 2025US 2025/0137021 A1Antheia, Inc.
- Auxotrophic Cells for Virus Production and Compositions and Methods of Making18 Apr 2024US 2024/0124850 A1Shape Therapeutics Inc.
Most cited
By later US patents
- Methods of treating Parkinson's disease using recombinant adeno-associated virus virions69US 7,588,757 B2Genzyme Corporation · 2009
- rAAV vector compositions, methods for targeting vascular endothelial cells and use in treatment of type I diabetes11US 10,648,000 B2University of Florida Research Foundation, Inc. · 2020
- Methods of producing nor-opioid and nal-opioid benzylisoquinoline alkaloids2US 10,738,335 B2Antheia, Inc. · 2020
- Optimized microbial cells for production of melatonin and other compounds1US 10,851,365 B2Danmarks Tekniske Universitet · 2020
- Methods of producing nor-opioid and nal-opioid benzylisoquinoline alkaloids1US 11,396,668 B2Antheia, Inc. · 2022